Skip to content

STENAPHAR

Absorbed by MULTIPHARMA on 12-06-2025 KBO/BCE: BE 0467.037.380

Last board

1 director, 1 auditor, last change in 2024
Director
appointed by deed of 08-02-2024
Statutory auditor, permanent representative
appointed by deed of 08-02-2024
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit en défendant.”
deed of 29-02-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director

Statutory auditor
Board
Mandates as a list
    • Director, appointed by deed of 08-02-2024, still in office
    • Statutory auditor, from 20-12-2023 to date
With Starter you also see 1 former office holder in the mandate history. See the plans →

See the board, name and registered office on a given date →

Control

STENAPHAR was absorbed by on 12-06-2025.

Capital

Contribution
€6,197.33
Source
2024 annual accounts

Owners through the years

as the annual accounts name them
100%
Owners as a list
    • 2023 to 2024: 100%

Source: lists of holdings in the owners' accounts

Articles of association

deed of 29-02-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Thursday of June at 17:00

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 24-06-2025 ↗
  • all shares
Capital over time
  1. 29-02-2024 Converted to unavailable equity